Back

The comorbidity network in older adults with atrial fibrillation: a danish nationwide cohort study

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Individual treatment strategies in atrial fibrillation Cardiovascular Disease in the Elderly ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Lu Dai

t, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis
Doctor H. Ahn (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Preterm birth, abnormal foetal growth and the risk of atrial fibrillation later in life: a cohort study in Denmark, Finland and Sweden
Miss F. Yang (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes in patients with atrial fibrillation with or without concomitant diabetes after two years of edoxaban treatment: ETNA-AF-Europe registry
Professor G. Patti (Novara, IT)
Abstract Slides Video
Presentation thumbnail
The AFLETES study: atrial fibrillation in veteran athLETEs and the risk of stroke
Doctor S. Pallikadavath (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Heart failure and cardiovascular outcomes in european patients with atrial fibrillation
Doctor N. Bonini (Modena, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Individual treatment strategies in atrial fibrillation

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis
thumbnail
Congress Presentation
The AFLETES study: atrial fibrillation in veteran athLETEs and the risk of stroke
thumbnail
Congress Presentation
Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection via the purinergic P2Y13 receptor and nitric oxide signalling

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources